GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
COVIDIEN LTD. COMMON SHARES (COV) [hlAlert]

Rating:
Overweight
COV
up 96.15 %

COVIDIEN LTD. COMMON SHARES (COV) rated Overweight with price target $77 by Barclays

Posted on: Thursday,  Dec 5, 2013  2:25 PM ET by Barclays

Barclays rated Overweight COVIDIEN LTD. COMMON SHARES (NYSE: COV) on 12/05/2013. Previously Barclays rated Overweight COVIDIEN LTD. COMMON SHARES (NYSE: COV) on
05/08/2012., when the stock price was $54.40. Since then, COVIDIEN LTD. COMMON SHARES has gained 96.16% as of 01/26/2016's recent price of $106.71.
If you would have followed the previous Barclays's recommendation on COV, you would have gained 96.15% of your investment in 1358 days.

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Surgical Devices, Energy-Based Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/18/2014 12:00 AM Buy
None
91.01 93.00
as of 12/13/2013
1 Week down  -3.32 %
1 Month up  1.02 %
3 Months up  8.86 %
1 YTD up  13.97 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/6/2014 12:25 PM Buy
None
72.09 82.00
12/5/2013 2:25 PM Buy
None
67.45 77.00
8/2/2013 1:25 PM Buy
None
63.18 72.00
5/7/2013 2:25 PM Buy
None
65.00 74.00
1/28/2013 1:25 PM Buy
None
62.55 70.00
5/8/2012 1:25 PM Buy
None
54.40 62.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy